United States Pharmaceuticals

Old API Wind-Down Ltd (ARLZQ)

Track

Ticker: ARLZQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 4 Jun 2018
Value US$298,073.75 | Price 378.28 | Shares 2,958 (+35.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-06-06 2018-06-04 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
2,958 +35.2%
378.28
US$298,074 		2,958 +35.2% 378.28 US$298,074
2018-05-16 2018-05-14 PlS Planned sale Tursi James Patrick

Chief Medical Officer

Officer
64,032 -41.7%
94.07
US$1,560,359 		64,032 -41.7% 94.07 US$1,560,359
2018-05-16 2018-05-14 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off

Officer
45,356 -39.1%
306.01
US$1,126,771 		45,356 -39.1% 306.01 US$1,126,771
2018-03-21 2018-03-19 PlS Planned sale Glickman Mark A

Chief Commercial Officer
5,725 -2.2%
1.70
US$9,732 		5,725 -2.2% 1.70 US$9,732
2018-03-21 2018-03-19 PlS Planned sale Trachtenberg Eric

GC, CCO & Secretary
3,471 -1.7%
1.70
US$5,901 		3,471 -1.7% 1.70 US$5,901
2018-03-21 2018-03-19 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
9,739 -0.7%
1.70
US$16,556 		9,739 -0.7% 1.70 US$16,556
2018-03-21 2018-03-19 PlS Planned sale Tursi James Patrick

Chief Medical Officer
5,950 -2.3%
1.70
US$10,115 		5,950 -2.3% 1.70 US$10,115
2017-12-12 2017-12-08 B Purchase Kirsch Arthur S
50,000 +22.6%
1.47
US$73,535 		50,000 +22.6% 1.47 US$73,535
2017-10-04 2017-10-02 PlS Planned sale Tursi James Patrick

Chief Medical Officer
9,960 -3.7%
2.50
US$24,918 		9,960 -3.7% 2.50 US$24,918
2017-07-28 2017-07-28 PlS Planned sale
Charles Scott J

Chief Financial Officer

Officer
10,804 -3.7%
1.25
US$13,509 		10,804 -3.7% 1.25 US$13,509
2017-06-23 2017-06-23 PlS Planned sale
Trachtenberg Eric

GC, CCO & Secretary
7,720 -3.7%
1.33
US$10,268 		7,720 -3.7% 1.33 US$10,268
2017-06-19 2017-06-15 B Purchase Kirsch Arthur S
15,000 +7.3%
1.15
US$17,181 		15,000 +7.3% 1.15 US$17,181
2017-06-16 2017-06-14 B Purchase Kirsch Arthur S
50,000 +31.9%
1.17
US$58,525 		50,000 +31.9% 1.17 US$58,525
2017-06-06 2017-06-05 S Sale
KOVEN ANDREW I

President & Chief Business Off
161,906 -10.6%
1.28
US$207,110 		161,906 -10.6% 1.28 US$207,110
2017-05-24 2017-05-23 S Sale Aryeh Jason Non-Executive Director
104,176 -100.0%
1.41
US$146,878 		104,176 -100.0% 1.41 US$146,878
2017-05-24 2017-05-22 S Sale Aryeh Jason Non-Executive Director
233,468 -69.1%
1.42
US$332,365 		233,468 -69.1% 1.42 US$332,365
2017-05-24 2017-05-19 S Sale Aryeh Jason Non-Executive Director
51,041 -13.1%
1.56
US$79,558 		51,041 -13.1% 1.56 US$79,558
2017-03-22 2017-03-20 PlS Planned sale
Charles Scott J

Chief Financial Officer
5,205 -2.4%
2.41
US$12,544 		5,205 -2.4% 2.41 US$12,544
2017-03-22 2017-03-20 PlS Planned sale
KOVEN ANDREW I

President & Chief Business Off
7,825 -0.5%
2.41
US$18,858 		7,825 -0.5% 2.41 US$18,858
2017-03-17 2017-03-15 B Purchase Kirsch Arthur S
45,000 +43.2%
2.27
US$102,249 		45,000 +43.2% 2.27 US$102,249
2017-03-17 2017-03-15 B Purchase KOVEN ANDREW I

President & Chief Business Off
20,000 +1.4%
2.55
US$50,920 		20,000 +1.4% 2.55 US$50,920
2017-03-17 2017-03-15 B Purchase Tursi James Patrick

Chief Medical Officer
4,750 +2.6%
2.11
US$10,022 		4,750 +2.6% 2.11 US$10,022
2017-03-17 2017-03-15 B Purchase ADAMS ADRIAN

Chief Executive Officer

Executive Director
500,000 +16.3%
2.46
US$1,230,950 		500,000 +16.3% 2.46 US$1,230,950
2017-03-17 2017-03-15 B Purchase RUDNICK SETH Non-Executive Director
15,000 +23.3%
2.26
US$33,950 		15,000 +23.3% 2.26 US$33,950
2017-03-17 2017-03-15 B Purchase LEE KENNETH B JR Non-Executive Director
5,000 +5.5%
2.52
US$12,618 		5,000 +5.5% 2.52 US$12,618
2016-11-30 2016-11-29 PlS Planned sale Harris Robert Paul Non-Executive Director
104,778 -15.0%
4.99
US$523,146 		104,778 -15.0% 4.99 US$523,146
2016-11-30 2016-11-28 PlS Planned sale Harris Robert Paul Non-Executive Director
20,000 -3.3%
4.65
US$93,000 		20,000 -3.3% 4.65 US$93,000
2016-11-15 2016-11-14 B Purchase LEE KENNETH B JR Non-Executive Director
1,000 +1.1%
4.95
US$4,950 		1,000 +1.1% 4.95 US$4,950
2016-11-15 2016-11-11 B Purchase RUDNICK SETH Non-Executive Director
30,000 +46.6%
4.77
US$143,121 		30,000 +46.6% 4.77 US$143,121
2017-04-25 2016-09-16 B Purchase Aryeh Jason
295,929 +625.8%
5.86
US$1,732,664 		295,929 +625.8% 5.86 US$1,732,664
2016-09-19 2016-09-15 PlS Planned sale Harris Robert Paul Non-Executive Director
75,000 -11.2%
6.04
US$453,218 		75,000 -11.2% 6.04 US$453,218
2016-09-19 2016-09-15 PlS Planned sale Harris Robert Paul Non-Executive Director
75,000 -10.1%
5.60
US$420,000 		75,000 -10.1% 5.60 US$420,000
2016-05-23 2016-05-20 B Purchase Tursi James Patrick

Chief Medical Officer

Officer
10,000 +5.9%
3.75
US$37,500 		10,000 +5.9% 3.75 US$37,500
2016-05-18 2016-05-16 B Purchase Glickman Mark A

Chief Commercial Officer

Officer
25,000 +15.5%
3.68
US$92,050 		25,000 +15.5% 3.68 US$92,050
2016-05-18 2016-05-16 B Purchase Trachtenberg Eric

GC, CCO & Secretary

Officer
10,000 +7.4%
3.76
US$37,570 		10,000 +7.4% 3.76 US$37,570
2016-05-18 2016-05-16 B Purchase Tursi James Patrick

Chief Medical Officer

Officer
4,500 +2.7%
3.79
US$17,037 		4,500 +2.7% 3.79 US$17,037
2016-05-17 2016-05-13 B Purchase LEE KENNETH B JR Non-Executive Director
1,000 +1.2%
3.50
US$3,500 		1,000 +1.2% 3.50 US$3,500
2016-05-16 2016-05-12 B Purchase Kirsch Arthur S Non-Executive Director
5,000 +inf%
3.49
US$17,450 		5,000 +inf% 3.49 US$17,450
2016-05-16 2016-05-12 B Purchase Kirsch Arthur S Non-Executive Director
22,500 +30.4%
3.49
US$78,548 		22,500 +30.4% 3.49 US$78,548
2016-05-16 2016-05-12 B Purchase Charles Scott J

Chief Financial Officer

Officer
50,000 +30.6%
3.49
US$174,495 		50,000 +30.6% 3.49 US$174,495
2016-05-13 2016-05-12 B Purchase KOVEN ANDREW I

President & Chief Business Off

Officer
71,500 +4.6%
3.49
US$249,471 		71,500 +4.6% 3.49 US$249,471
2016-04-07 2016-03-17 S Sale QLT INC/BC Large shareholder
2,400,000 -33.3%
6.25
US$15,000,000 		2,400,000 -33.3% 6.25 US$15,000,000
Explore more

More insider trading research around Old API Wind-Down Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America